OBJECTIVE: The aim of this study is testing the value of H-FABP in the early diagnosis of ACS alone or with routinely used biomarkers such as myoglobin, CK-MB, and cTn I in patients who admitted to emergency department (ED) with complaint of chest pain and suspected acute coronary syndrome. MATERIAL AND METHODS: This prospective and cross-sectional study was performed at the Emergency Department of University hospital between June 2009 and September 2010. Patients who were admitted with chest pain within first 48 hours and suspected ACS were enrolled to the study. Blood samples were taken for CK-MB, myoglobin, cTnI and H-FABP The patients were divided into two groups (ACS and non ACS). Statistical analyse were used for relation of biomarkers with diagnosis of ACS. RESULTS: A 66 patients were included to the study. H-FAPB values were positive in 15.2% patients. When H-FABP was added to routinely used biomarkers in the diagnosis of ACS, increasing was observed in all sensitivity, specificity, PPV and NPV values. However, this increase was not statistically significant. CONCLUSION: H-FABP did not provide any significant change in early diagnosis and exclusion of ACS diagnosis when used either alone or combination with routinely used biomarkers.
OBJECTIVE: The aim of this study is testing the value of H-FABP in the early diagnosis of ACS alone or with routinely used biomarkers such as myoglobin, CK-MB, and cTn I in patients who admitted to emergency department (ED) with complaint of chest pain and suspected acute coronary syndrome. MATERIAL AND METHODS: This prospective and cross-sectional study was performed at the Emergency Department of University hospital between June 2009 and September 2010. Patients who were admitted with chest pain within first 48 hours and suspected ACS were enrolled to the study. Blood samples were taken for CK-MB, myoglobin, cTnI and H-FABP The patients were divided into two groups (ACS and non ACS). Statistical analyse were used for relation of biomarkers with diagnosis of ACS. RESULTS: A 66 patients were included to the study. H-FAPB values were positive in 15.2% patients. When H-FABP was added to routinely used biomarkers in the diagnosis of ACS, increasing was observed in all sensitivity, specificity, PPV and NPV values. However, this increase was not statistically significant. CONCLUSION:H-FABP did not provide any significant change in early diagnosis and exclusion of ACS diagnosis when used either alone or combination with routinely used biomarkers.
Entities:
Keywords:
acute coronary syndrome; biomarker; heart-type fatty acid-binding protein
Authors: Jean-Pierre Bassand; Christian W Hamm; Diego Ardissino; Eric Boersma; Andrzej Budaj; Francisco Fernández-Avilés; Keith A A Fox; David Hasdai; E Magnus Ohman; Lars Wallentin; William Wijns Journal: Eur Heart J Date: 2007-06-14 Impact factor: 29.983
Authors: Devin W Kehl; Navaid Iqbal; Arrash Fard; Ben A Kipper; Alejandro De La Parra Landa; Alan S Maisel Journal: Transl Res Date: 2011-12-07 Impact factor: 7.012
Authors: F Okamoto; K Sohmiya; Y Ohkaru; K Kawamura; K Asayama; H Kimura; S Nishimura; H Ishii; N Sunahara; T Tanaka Journal: Clin Chem Lab Med Date: 2000-03 Impact factor: 3.694
Authors: Jun Liao; Cangel Pui-yee Chan; Yiu-chi Cheung; Jian-hua Lu; Yi Luo; George W H Cautherley; Jan F C Glatz; Reinhard Renneberg Journal: Int J Cardiol Date: 2008-06-20 Impact factor: 4.164
Authors: Hector Alonso Valle; Luis García-Castrillo Riesgo; Miguel Sántalo Bel; Francisco Epelde Gonzalo; Miguel Sánchez Sanchez; Luis Iglesias Oliva Journal: Eur J Emerg Med Date: 2008-06 Impact factor: 2.799